8:15 am
Jianguo Cheng
Jianguo Cheng, MD, PhD
Professor, Anesthesiology; Director, Multidisciplinary Pain Medicine Fellowship Program
Cleveland Clinic
President,
American Academy of Pain Medicine
Member,HHS Pain Management Inter-Agency Task Force

8:30 am

Recommendations as to how to best address the opioid crisis, by way of funding allocations, guidelines, and regulations, are being made at both the federal and state level. In this panel discussion, hear how various organizations are taking those recommendations and putting them into practice.

  • Examine the updates to pain management guidelines
  • Hear how organizations have overcome implementation challenges affecting clinical processes, provider prescriber practices, provider decision making, and value-based care initiatives
  • Determine what changes need to be made to support new policies and the resources necessary to implement them
  • Leverage decision support tools at the point of care to reduce opioid prescriptions

Moderator:

Cedric A. Terrell
Cedric A. Terrell, PharmD, MHA
Senior Vice President, Pharmacy Services
Novant Health

Panelists:

Jason Brown
Jason Brown, MD, FACP
Chief Medical Officer,
Banner Pharmacy Services and
Health Transfer Services

Jianguo Cheng
Jianguo Cheng, MD, PhD
Professor, Anesthesiology; Director, Multidisciplinary Pain Medicine Fellowship Program
Cleveland Clinic
President,
American Academy of Pain Medicine
Member,HHS Pain Management Inter-Agency Task Force

Jeannie S. Huang
Jeannie S. Huang, MD, MPH
Chair, Opioid Prescription Task Force
Rady Children's Hospital - San Diego

9:15 am

Drug take back programs have been an overlooked and underutilized component of a comprehensive opioid crisis response strategy, but they are rapidly gaining awareness and popularity. Compliance with government regulations for these programs can be a challenge – managing multiple waste streams and regulations can distract from patient care or customer service, while mistakes or oversight can result in serious regulatory consequences. Hear from a 20-year regulated medical waste industry veteran about the latest regulations and best practices for drug take back programs and how an experienced partner can ensure compliant, high-impact results. In this session, we will:

  • Make the case for safe medication disposal & drug take back as an essential opioid abuse prevention strategy
  • Review regulatory requirements, the legislative landscape, and funding sources for drug take back programs
  • Recommend best practices for implementing and managing a drug take back program based on learnings from operating drug take back programs over the last 3 years
Selin Hoboy
Selin Hoboy
Vice President, Legislative & Regulatory Affairs
Stericycle, Inc.

10:30 am

While the drug misuse epidemic continues to be a public health crisis in the U.S. , the nature of the misuse is shifting. Misuse of some drugs shows signs of decline in certain populations, but explosive growth in others. Learn about the most recent trends on the evolving patterns of misuse, analyzed from over 3.9 million drug monitoring tests performed by Quest Diagnostics between 2011 and 2017 and how these insights can help better educate providers, improve patient care, and establish system-wide protocols for prescribing and monitoring controlled substances such as opioids, benzodiazepines, and amphetamines.

  • Assess the current drug misuse trends, including who is misusing and which drugs are increasingly prevalent
  • Learn about the benefits of clinical drug testing as an objective tool to help reduce risks associated with chronic use of controlled substances
  • Identify the elements to consider when implementing a responsible drug monitoring protocol across your organization
Jack Kain
Jack Kain, PharmD
Director, Medical Science Liaison, Prescription Drug Monitoring and Toxicology
Quest Diagnostics

11:15 am

Population health data provides organizations a better picture of provider prescribing patterns as well as patient use. In this case study, hear how to use data to identify prescribers with sub-optimal prescribing patterns as well as individuals most likely to benefit from opioid alternative programs. Then learn how the organization is using targeted education and focused outreach to ensure appropriate prescribing while still addressing the pain management needs of patients.

  • Hear the benchmarks being used to “flag” data in population health reports, such as the duration of prescriptions or the number of distinct prescribers
  • Learn about algorithms created to identify patients most likely to benefit from opioid alternative programs, and provider education efforts to support appropriate referrals for those patients
Daniel J. Durand
Daniel J. Durand, MD
Chief Innovation Officer; Chair, Radiology
Lifebridge Health

12:00 pm

Although medication-assisted treatment (MAT) is recommended as effective treatment for opioid dependence, its use has not kept pace with that of opioid dependence diagnoses. A MAT option associated with lower healthcare utilization and costs will be discussed. New studies regarding comparable efficacy, upon initiation of therapy, of some MAT options will also be reviewed.

Hosted By:

    
Jeffrey A. Berman
Jeffrey A. Berman, MD, FAFSAM
Clinical Assistant Professor of Psychiatry,
Rutgers Robert Wood Johnson Medical School
Medical Director
SOBA College Recovery

*Dr. Berman is a paid consultant for Alkermes, Inc.

1:15 pm

Steps taken over a decade have enabled a large health care system to reduce opioid utilization by building a culture of low-opioid reliance. Hear how the system was able to accomplish this by examining published outcome data, and details surrounding the utilization of the ECHO model (tele-mentoring). See the results achieved by reviewing the data comparing opioid use in this system versus others in its the region (Northeast Ohio).

  • Describe how adherence to evidence-based pain management can lead to low-opioid reliance
  • Describe tools used for safety and audit of opioid prescribing
  • Share data and describe how innovative technologies and tele-mentoring of primary care led to change in prescribing practices
Ali Mchaourab
Ali Mchaourab, MD
Associate Professor, Anesthesiology
Case Western Reserve University
Staff Physician, Pain Medicine Service
Cleveland VA Medical Center

2:00 pm

Equipping primary care providers with education, governance, and other tools can enable organizations to reduce overexposure to opioids in the primary care setting. Learn how University Hospitals achieved a reduction in the number of opioids prescribed in primary care by 1.5 million through those types of efforts.

  • Outline the standards for education set up for providers
  • Build accountability to educational standards for safe prescribing through a governance structure and tools in the EMR
  • Learn about the Pain Management Institute that was developed to give providers and their patients a resource and referral options for those with comorbidities, including other behavioral health concerns, and/or chronic pain
Randy Jernejcic
Randy Jernejcic, MD, MMM
Vice President,
Clinical Integration
University Hospitals

3:15 pm

A competent, collaborative, inter-professional team centered on the patient and proper treatment is necessary for quality pain and symptom management. However, established models of inter-professional collaborative practice are not yet standardized nationally. By developing an inter-professional team, comprehensive quality patient-centered care can be delivered in a way in which patients with multi-diagnoses can be treated wholistically, effectively, and the providers feel supported in making treatment decisions. Examine cases where an integrated team dynamic provided specific interventions that have served as successful models for the management of patients with both pain and Substance Use Disorder.

  • Discuss ways to enable a robust collaborative practice and improve pain management for safe and empathetic treatment of poly-substance abuse patients
  • Identify the overlapping responsibilities of screening, dispensing, and monitoring to ensure the most efficient and effective care
  • Examine practical team-based interventions and universal precautions to administer to patients with pain and comorbid SUD in the settings of palliative care, hospice, and chronic, non-malignant pain
Daniel P Gorman
Daniel P Gorman, NP-C, MSN, OCN
Nurse Practitioner - Palliative Care, Director, Adult Palliative Care Clinic
Dana Farber Cancer Institute

Benjamin S. Kematick
Benjamin S. Kematick, PharmD
Clinical Pharmacy Specialist, Palliative Care
Dana Farber Cancer Institute

Lee Kral
Lee Kral, PharmD, BCPS, CPE
Clinical Pharmacy Specialist, Pain Management
The University of Iowa Hospitals And Clinics Center For Pain Medicine
Adjunct Assistant Professor, Carver College of Medicine, Department of Anesthesia
University of Iowa

Tejinder Swaran Singh
Tejinder Swaran Singh, MBBS, FRCA
Clinical Assistant Professor, Chronic Pain Medicine, Acute Pain, and Regional Anesthesia
Carver College of Medicine
Department of Anesthesia
University of Iowa

4:00 pm

To ensure appropriate prescribing behaviors and patient use of opioids, organizations are focusing on patient and provider education and monitoring. In this panel, discuss opportunities to enhance provider and patient education around pain management and responsible prescribing.

  • Identify effective continuing education and workflow adaptations to impact opioid prescribing practices, screening, monitoring, patient communication, consideration of alternative therapies for multi-modal treatment, and the psycho-social elements of treatment
  • Define effective partnerships that promote continuity in education between medical school, post graduate, and the community
  • Explore ways to address stigma and the culture change of determining appropriate opioid limits on balance to patient needs and satisfaction scores

Moderator:

Dahlia Rizk
Dahlia Rizk, DO, MPH
Chief, Hospital Medicine, President, Medical Board, Mount Sinai Beth Israel Medical Center, Vice President, Physician and Patient Access, Mount Sinai Downtown Associate Professor, Icahn School of Medicine

Panelists:

P. Marlene Capps
P. Marlene Capps, MD
Chief Medical Officer
Bon Secours Mary Immaculate Hospital

Kathy L. Doub
Kathy L. Doub, RPh
Vice President, Pharmacy Operations
Novant Health

Jason Fodeman
Jason Fodeman, MD, MBA
Health Policy Expert

4:45 pm

Efforts to address the opioid crisis within the hospital or health system can be siloed, and often times lack comparable benchmarks. Organizations are using Opioid Stewardship Programs to break down siloes within the hospital and health system, and improve their collaborative efforts with partners such as health plans, treatment facilities, community organizations, and government agencies. Gain insight into the successes of these programs and participate in discussion around the formulation of benchmarks to better determine what success looks like and how to measure it.

  • Learn how organizations are incorporating insights from public health data, recommendations, and other sources in systemwide policy development
  • Discover benchmarks, metrics, and best practices being used for screening, sharing data, and treating pain
  • Ensure alignment and a multi-disciplinary approach both within the hospital and health system as well as with other key health care and community stakeholders
  • Share ways to reduce stigmas and improve education for both prescribers and patients
Mark Bicket
Mark Bicket, MD
Director, Multidisciplinary Pain Medicine Fellowship
Johns Hopkins Medicine

Bridget Bridgman
Bridget Bridgman, PharmD, CPPS
Director, Medication Safety
Novant Health